Northwest Biotherapeutics
(OTC) NWBO
Northwest Biotherapeutics Financials at a Glance
Market Cap
$311.73M
Revenue (TTM)
$1.38M
Net Income (TTM)
$60.43M
EPS (TTM)
$-0.04
P/E Ratio
-4.52
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.19
Volume
5,122,149
Open
$0.20
Price
$0.19
Volume
5,122,149
Open
$0.20
Previous Close
$0.19
Daily Range
$0.19 - $0.20
52-Week Range
$0.19 - $0.38
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.19
Volume
5,122,149
Open
$0.20
Previous Close
$0.19
Daily Range
$0.19 - $0.20
52-Week Range
$0.19 - $0.38
NWBO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Northwest Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
25
CEO
Linda F. Powers
Website
www.nwbio.comHeadquarters
Bethesda, MD 20814, US
NWBO Financials
Key Financial Metrics (TTM)
Gross Margin
4%
Operating Margin
-43%
Net Income Margin
-44%
Return on Equity
0%
Return on Capital
6%
Return on Assets
-74%
Earnings Yield
-22.12%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$311.73M
Shares Outstanding
1.61B
Volume
5.12M
Short Interest
0.00%
Avg. Volume
2.31M
Financials (TTM)
Gross Profit
$959.00K
Operating Income
$59.91M
EBITDA
$57.58M
Operating Cash Flow
$44.76M
Capital Expenditure
$1.50M
Free Cash Flow
$46.27M
Cash & ST Invst.
$3.04M
Total Debt
$64.83M
Northwest Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$672.00K
+190.9%
Gross Profit
$129.00K
-155.8%
Gross Margin
-19.20%
N/A
Market Cap
$311.73M
N/A
Market Cap/Employee
$12.47M
N/A
Employees
25
N/A
Net Income
$1.39M
+104.9%
EBITDA
$12.70M
+49.7%
Quarterly Fundamentals
Net Cash
$61.79M
+5.3%
Accounts Receivable
$311.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$22.29M
-31.9%
Short Term Debt
$42.54M
+22.6%
Return on Assets
-74.34%
N/A
Return on Invested Capital
5.76%
N/A
Free Cash Flow
$15.16M
+25.2%
Operating Cash Flow
$14.76M
+26.8%